Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 992  

    Article Cited by others


Radioiodine Thyroid Ablation in Graves' Hyperthyroidism: Merits and Pitfalls

Nwatsock J F, Taieb D, Tessonnier L, Mancini J, Dong-A-Zok F, Mundler O

Year : 2012| Volume: 11| Issue : 1 | Page no: 7-11

   This article has been cited by
1 Double-layer carbon nanocapsules with radioiodine content and its interaction with calcium, phosphorus, and strontium
Alejandro Valderrama,Radamés Reynoso,Raúl W. Gómez,Manuel Quintana,Martín Romero
Journal of Molecular Modeling. 2018; 24(1)
[Pubmed]  [Google Scholar] [DOI]
2 Interactions of calcium with the external surfaces of fullerenes and endofullerenes doped with radioactive sodium iodide
Alejandro Valderrama,Radamés Reynoso,Raúl W. Gómez,Vivianne Marquina,Martín Romero
Journal of Molecular Modeling. 2017; 23(1)
[Pubmed]  [Google Scholar] [DOI]
3 Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders
Lavinia Vija Racaru,Charlotte Fontan,Mathilde Bauriaud-Mallet,Séverine Brillouet,Olivier Caselles,Slimane Zerdoud,Delphine Bastié,Delphine Vallot,Philippe Caron,Manuel Bardiès,Frederic Courbon
Nuclear Medicine Communications. 2017; 38(9): 756
[Pubmed]  [Google Scholar] [DOI]
4 Radioiodine therapy for benign thyroid diseases (version 5)
M. Dietlein,F. Grünwald,M. Schmidt,P. Schneider,F. A. Verburg,M. Luster
Nuklearmedizin. 2016; 55(6): 213
[Pubmed]  [Google Scholar] [DOI]
5 Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Gravesæ hyperthyroidism undergoing radioiodine therapy: a randomized controlled study
David Taïeb,Claire Bournaud,Marie-Claude Eberle,Bogdan Catargi,Claire Schvartz,Marie-Béatrice Cavarec,Isabelle Faugeron,Marie-Elisabeth Toubert,Danielle Benisvy,Cendrine Archange,Olivier Mundler,Philippe Caron,Ahmad Esmaeel Abdullah,Karine Baumstarck
European Journal of Endocrinology. 2016; 174(4): 491
[Pubmed]  [Google Scholar] [DOI]
6 Optic Neuropathy in 2 Thyroidectomized Patients with Moderate to Severe Graves Ophthalmopathy Following L-Thyroxine Withdrawal Prior to Radioiodine Treatment for Thyroid Carcinoma
Roberto Rocchi,Maria Antonietta Altea,Michele Marinò,Francesca Menconi,Marenza Leo,Eleonora Sisti,Maria Antonietta Profilo,Paola Lepri,Marco Nardi,Paolo Vitti,Claudio Marcocci,Francesco Latrofa
AACE Clinical Case Reports. 2015; 1(2): e119
[Pubmed]  [Google Scholar] [DOI]
7 Factors influencing the success of radioiodine therapy in patients with Graves’ disease
Daša Šfiligoj,Simona Gaberšcek,Polona Jaki Mekjavic,Edvard Pirnat,Katja Zaletel
Nuclear Medicine Communications. 2015; 36(6): 560
[Pubmed]  [Google Scholar] [DOI]
8 Radioactive Iodine Therapy and Thyroid Eye Disease From an Ophthalmologist’s Perspective
Catherine J. Choi,Aubrey L. Gilbert,Nahyoung G. Lee
International Ophthalmology Clinics. 2015; 55(4): 63
[Pubmed]  [Google Scholar] [DOI]
9 Medical Management of Extrathyroidal Manifestation of Graves Disease
Vahab Fatourechi
Endocrine Practice. 2014; 1(-1): 1
[Pubmed]  [Google Scholar] [DOI]


Read this article